(NASDAQ: MOLN) Molecular Partners Ag's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.
Molecular Partners Ag's earnings in 2026 is -$74,362,962.On average, 5 Wall Street analysts forecast MOLN's earnings for 2026 to be -$56,701,767, with the lowest MOLN earnings forecast at -$72,189,681, and the highest MOLN earnings forecast at -$23,164,564. On average, 4 Wall Street analysts forecast MOLN's earnings for 2027 to be -$17,163,091, with the lowest MOLN earnings forecast at -$86,114,594, and the highest MOLN earnings forecast at $56,929,860.
In 2028, MOLN is forecast to generate -$117,079,203 in earnings, with the lowest earnings forecast at -$112,487,422 and the highest earnings forecast at -$120,523,039.